Pulmonary embolism is an uncommon but potentially life-threatening event in children.
There has been increasing awareness of pulmonary embolism in children with improved …

Comorbidity scores are widely used to help address confounding bias in nonrandomized
studies conducted within health-care databases, but existing scores were developed to …

Anticoagulation therapy is standard for conditions like atrial fibrillation, venous
thromboembolism, and valvular heart disease, yet it is unclear if there are ethnoracial …

Abstract Background The EINSTEIN-Jr program will evaluate rivaroxaban for the treatment
of venous thromboembolism (VTE) in children, targeting exposures similar to the 20 mg …

Thromboembolic disease rates are increasing in pediatric patients. Anticoagulation is
prescribed for treatment and prevention of thromboembolic disease. While nonadherence to …

Background Deep venous thrombosis (DVT) of the lower extremity causes a major disease
burden globally. Currently, oral anticoagulant therapy is used as the first-line treatment of …

OBJECTIVES The purposes of this study are to perform a large-scale evaluation of the
standardized dosage adjustment nomogram recommended by the American College of …

Hospital-acquired venous thromboembolism (VTE) affects morbidity and mortality and
increases health care costs. Poor adherence to recommended prophylaxis may be a …

Warfarin is the most commonly prescribed anticoagulant for children in the outpatient setting
in Australia. Pediatric patients likely have different challenges to warfarin adherence …

Background: Thromboembolism (TE) in pediatric population is rare but may be a fatal
situation. There is a lack of clinical guidelines to help decision making for the use of …